Voyager Therapeutics (VYGR) Interest Coverage Ratio (2014 - 2026)

Voyager Therapeutics (VYGR) has 13 years of Interest Coverage Ratio data on file, last reported at 0.75 in Q1 2026.

• For the quarter ending Q1 2026, Interest Coverage Ratio rose 96.85% year-over-year to 0.75; the trailing twelve-month figure through Mar 2026 stood at 3.17 (up 95.47% YoY), and the FY2025 full-year result was 0.91, down 15.28% from the prior year.
• Interest Coverage Ratio retreated to 0.75 in Q1 2026, from 0.21 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 11.56 in Q1 2023 to a low of 269.92 in Q4 2022.
• A 5-year average of 19.46 and a median of 1.58 in 2024 frame the typical range for Interest Coverage Ratio.
• Peak annual rise in Interest Coverage Ratio reached 691.06% in 2022, while the deepest fall reached 509285.13% in 2022.
• Tracing VYGR's Interest Coverage Ratio over 5 years: stood at 269.92 in 2022, then soared by 100.24% to 0.65 in 2023, then plunged by 4778.14% to 30.61 in 2024, then jumped by 99.33% to 0.21 in 2025, then sank by 266.16% to 0.75 in 2026.
• Business Quant data shows VYGR's Interest Coverage Ratio at 0.75 in Q1 2026, 0.21 in Q4 2025, and 3.83 in Q3 2025.